#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuromyelitis optica spectrum disorder Fontan procedure Lymphangiosarcoma Breast angiosarcoma metastatic Lymphoma Vernal keratoconjunctivitis Skin cancer Gastroenteropancreatic neuroendocrine tumour disease Essential thrombocythaemia Wiskott-Aldrich syndrome Squamous cell carcinoma of the oral cavity Haemophilia Rosai-Dorfman syndrome Oropharyngeal squamous cell carcinoma Hidradenitis More trials…

    Learn about Rare Diseases

    Isodicentric chromosome 15 syndrome Arterial tortuosity syndrome – Diagnostics Congenital generalised lipodystrophy Krabbe’s disease – Trials in Disease Biotinidase deficiency – Treatment Optic glioma – Life with Disease Mucopolysaccharidosis III – Life with Disease Urea cycle disorder – Diagnostics Breast angiosarcoma Congenital nephrogenic diabetes insipidus – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vanglusagene Ensiparvovec Resatorvid Mometasone Furoate Heparin Calcium Dolutegravir Prax-628 Nvdx3 Bms-986449-03 Camizestrant GS-1720 Isavuconazonium Sulfate Betamethasone Acetate 10-1074-Ls Ertapenem Sodium Rocuronium Bromide Venetoclax Rbl027.2 Dermatophagoides Farinae Deucravacitinib Streptococcus Agalactiae More therapies…

    Learn about Your Condition

    Cervix carcinoma stage II Tardive dyskinesia Fungal infection Pulmonary hypertension CADASIL Breast cancer stage II Procedural pain Gastrointestinal disorder Intestinal infarction Biliary adenoma Endometrial cancer stage III Sarcoidosis Brain cancer metastatic H1N1 influenza Red blood cell abnormality More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut de Cancérologie Hématologie Universitaire…

Institut de Cancérologie Hématologie Universitaire de Saint Etienne (iCHUSE)

Avenue Albert Raimond, Saint Priest En Jarez, 42270, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study comparing intranasal COVID-19 vaccine (LVT-001) with mRNA vaccine (bretovameran) as booster doses in healthy adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • LVT-001
    France

  • Study on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Abemaciclib
    • Anastrozole
    • Exemestane
    Austria Belgium France Germany Italy The Netherlands +3

  • Study on Digital Monitoring of Symptoms in Patients with Advanced Kidney Cancer Treated with Cabozantinib and Nivolumab

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cabozantinib
    • Nivolumab
    France

  • Study on Azacitidine, Roginolisib, and Golcadomide for Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Azacitidine
    • Golcadomide
    • Roginolisib
    France

  • Study on Optimizing NALIRIFOX and 5-FU for Metastatic Pancreatic Cancer in First-Line Treatment and Exploring Ciprofloxacin in Second-Line Therapy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Ciprofloxacin
    • Fluorouracil
    • Gemcitabine
    France

  • Study on the Effectiveness and Safety of Tagraxofusp and Venetoclax for Adults with Untreated Blastic Plasmacytoid Dendritic Cell Neoplasm

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • TAGRAXOFUSP
    • Venetoclax
    France

  • Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone
    Belgium France

  • Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ro7790121
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Hypertension
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9
Previous Page
1 … 6 7 8 9 10 … 46
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!